Navigation Links
BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
Date:1/7/2009

SAN ANTONIO, Jan. 7 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a cutting edge medical device company focused on the development of orthopaedic memory metal implants, announced today that it has appointed Kenneth I. Moch as its President and Chief Executive Officer. W. Casey Fox, PhD, P.E., BME's Founder, will become Chief Technology Officer and continue to focus his efforts on building BME's innovative product offerings.

BME specializes in nitinol implants that contract and compress bone after implantation, bringing bone ends together to promote bone union. These proprietary implants allow the surgeon to finely control the amount of compression and rate of force application generated on bones, thereby reducing fractures and stimulating bone healing.

"Ken is a proven leader who brings extensive senior management and operational experience to BME, as well as a shared strategic vision to create a leading medical device company," said Richard M. Johnston, Chairman of BME and Managing Member of Camden Partners Holdings, LLC.

Mr. Moch has served as the President of Euclidean Life Science Advisors, which provides strategic advisory services to life sciences companies, since early 2008. He previously was Managing Director, Healthcare Investment Banking at ThinkEquity Partners and Chairman, President and CEO of Alteon, Inc., a biotech company specializing in small molecule therapeutics for cardiovascular aging and diabetic complications. Mr. Moch earlier served as President and CEO of Biocyte Corporation, the cellular therapy company that pioneered the collection and commercial application of cord blood stem cells, and as a management consultant with McKinsey & Company, Inc. Mr. Moch holds a degree in biochemistry from Princeton University and an MBA from the Stanford Graduate School of Business.

"It is a privilege to be joining BME at this exciting time in the company's history," said Mr. Moch. "I believe that BME's unique technology and innovative products have tremendous commercial growth potential. Together with BME's talented employees, I look forward to accelerating the growth of the Company and broadening the use of our novel memory metal implants."

"Ken's involvement is a statement to our distributor partners that we intend to grow our business for our mutual benefit. With in-house manufacturing now on line at BME we have the capability, support and focus for new product development and the continued improvement of our product lines," said Casey Fox, PhD.

About BioMedical Enterprises, Inc.

BME designs, manufactures and markets memory metal implants used in orthopaedic reconstructive surgery and fracture management. BME's patented implant system utilizes the unique properties of the shape memory alloy nitinol to provide controlled long-term compression that enhances the body's natural healing process in an effort to achieve faster healing times and fewer complications. BME's barbed and smooth OSStaple(TM) lines of bone fusion implants, part of the OSSforce(TM) fixation system, are designed to achieve controlled long-term compression of bone fragments. BME's OSSAnchor(TM) line of soft tissue fixation implants give surgeons a simple yet powerful tool to attach soft tissue to bone.

For more information about BME and its unique products visit http://www.bme-tx.com.


'/>"/>
SOURCE BioMedical Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
2. Response Biomedical Corporation Announces Change of Executives
3. AutismActionPlan.org Launches Doctor-Driven Biomedical Autism Treatment Website
4. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
5. ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research
6. Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
7. Environmental Tectonics Corporations BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers
8. Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases
9. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
10. Interview with Dr. Elisabeth Hager, CEO of Balan Biomedical, Inc., to Air Nationally on Sky Radio
11. Response Biomedical Closes $5.1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: